Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

HC Wainwright & Co. Maintains Buy on MiMedx Group, Lowers Price Target to $8

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains MiMedx Group (NASDAQ:MDXG) with a Buy and lowers the price target from $8.5 to $8.
byBenzinga Newsdesk
September 7, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains MiMedx Group (NASDAQ:MDXG) with a Buy and lowers the price target from $8.5 to $8.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts